+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Multiomics Market by Product, Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889740
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Multiomics Market grew from USD 83.55 billion in 2023 to USD 96.86 billion in 2024. It is expected to continue growing at a CAGR of 16.26%, reaching USD 239.92 billion by 2030.

Multiomics is an integrative approach that gathers comprehensive data from various "omics" fields, such as genomics, proteomics, transcriptomics, and metabolomics, to provide a holistic understanding of biological systems. This strategy is essential in areas like personalized medicine, where understanding the complex interactions between genes, proteins, and metabolites can lead to more targeted therapies and interventions. Applications of multiomics span drug discovery, disease diagnostics, and precision agriculture, with healthcare and biotechnology industries being the primary end-users. The growing interest in personalized medicine and the rise of big data analytics in healthcare are major driving forces behind the market's expansion. Increasing investments in research and development by leading biotech firms and collaborations across academia and industry further bolster market growth.

However, challenges such as high costs associated with multiomics research and data integration complexity pose significant barriers. Limited expertise in managing and interpreting multi-layered omics data also hampers widespread adoption. To overcome these challenges, businesses can innovate by developing cost-effective multiomics platforms and enhancing data analysis tools powered by AI and machine learning. Such innovations could lead to more streamlined processes and accurate predictions, encouraging wider application across various sectors. In terms of market opportunities, there is a growing demand for advanced diagnostics and therapeutics, fueled by the rising prevalence of chronic diseases. Companies can capitalize on this trend by leveraging multiomics to develop novel biomarkers and therapeutic targets.

To maximize growth, market players should focus on building strategic partnerships and investing in workforce training to handle complex data integration. Joining forces with tech companies could also provide a competitive edge in managing data and developing state-of-the-art analytical tools. While the multiomics market is poised for growth, constant advancements in analytical technologies and data management solutions are crucial to addressing existing limitations and unlocking its full potential, ensuring sustained innovation and business expansion.

Understanding Market Dynamics in the Multiomics Market

The Multiomics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
    • High potential owing to a growing preference towards personalized medicines
    • Rising research & development activities conducted by biotechnology companies
  • Market Restraints
    • High cost and limited skilled professionals associated with multiomics
  • Market Opportunities
    • Growing integration of advanced technologies into multiomics
    • Increasing investments in agriculture research and environmental science with sustainability targets
  • Market Challenges
    • Limited standard protocols for data acquisition, storage, and sharing across omics studies

Exploring Porter’s Five Forces for the Multiomics Market

Porter’s Five Forces framework further strengthens the insights of the Multiomics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Multiomics Market

External macro-environmental factors deeply influence the performance of the Multiomics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Multiomics Market

The Multiomics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Multiomics Market

The Multiomics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Multiomics Market

The Multiomics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
    • Instrument
    • Software
  • Type
    • Epigenomics
    • Genomics
    • Metabolomics
    • Microbiomics
    • Proteomics
    • Transcriptomics
  • Application
    • Agriculture & Plant Science
    • Diagnostics
    • Drug Discovery
    • Precision Medicine
  • End-User
    • Academic & Research Institutes
    • Biotechnology Companies
      • Agriculture
      • Environmental Science
      • Forensics
      • Plant & Animal Breeding
    • Hospitals & Clinics
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
5.1.1.2. High potential owing to a growing preference towards personalized medicines
5.1.1.3. Rising research & development activities conducted by biotechnology companies
5.1.2. Restraints
5.1.2.1. High cost and limited skilled professionals associated with multiomics
5.1.3. Opportunities
5.1.3.1. Growing integration of advanced technologies into multiomics
5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
5.1.4. Challenges
5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Multiomics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instrument
6.4. Software
7. Multiomics Market, by Type
7.1. Introduction
7.2. Epigenomics
7.3. Genomics
7.4. Metabolomics
7.5. Microbiomics
7.6. Proteomics
7.7. Transcriptomics
8. Multiomics Market, by Application
8.1. Introduction
8.2. Agriculture & Plant Science
8.3. Diagnostics
8.4. Drug Discovery
8.5. Precision Medicine
9. Multiomics Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology Companies
9.3.1. Agriculture
9.3.2. Environmental Science
9.3.3. Forensics
9.3.4. Plant & Animal Breeding
9.4. Hospitals & Clinics
9.5. Pharmaceutical & Biopharmaceutical Companies
10. Americas Multiomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Multiomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Multiomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
13.3.2. Biomodal Launches New Multiomics Sequencing Technology
13.3.3. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
13.3.4. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MULTIOMICS MARKET RESEARCH PROCESS
FIGURE 2. MULTIOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MULTIOMICS MARKET DYNAMICS
TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROBIOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE & PLANT SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY PLANT & ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 49. CANADA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CANADA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 54. MEXICO MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 76. CHINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. CHINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. CHINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CHINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CHINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 81. INDIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 91. JAPAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. JAPAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. JAPAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. JAPAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. JAPAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 121. THAILAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. THAILAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. THAILAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. THAILAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. THAILAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. DENMARK MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. DENMARK MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. DENMARK MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. DENMARK MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 142. EGYPT MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. EGYPT MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. EGYPT MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. EGYPT MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 147. FINLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FINLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FINLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. FINLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. FRANCE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. FRANCE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. FRANCE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 157. GERMANY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. GERMANY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. GERMANY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 167. ITALY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. ITALY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. ITALY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. ITALY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. ITALY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 182. NORWAY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. NORWAY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. NORWAY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. NORWAY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. NORWAY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 187. POLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. POLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 192. QATAR MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. QATAR MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. QATAR MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. QATAR MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 212. SPAIN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SPAIN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SPAIN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SPAIN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. TURKEY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 243. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Multiomics Market, which are profiled in this report, include:
  • 10x Genomics, Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Berkeley Lights, Inc.
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Celsee
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dolomite Bio by Unchained Labs
  • EpiCypher, Inc.
  • Google LLC by Alphabet Inc.
  • Illumina, Inc.
  • Miltenyi Biotec
  • Mission Bio, Inc.
  • Multiomic Health Limited
  • NanoCellect Biomedical
  • NanoString Technologies, Inc.
  • Novo Nordisk A/S
  • Olink Proteomics AB
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Singleron Biotechnologies GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tempus Labs, Inc.
  • Thermo Fischer Scientific Inc.

Methodology

Loading
LOADING...

Table Information